Immune response activation following hyperthermic intraperitoneal chemotherapy for peritoneal metastases: A pilot study

BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastases (PM) is considered to be feasible, safe and to improve survival. AIM: To investigate whether an immune response is activated following HIPEC for PM. METHODS: Six patients were enrolled in this study. Peripheral b...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World J Clin Oncol
Hlavní autoři: Fiorentini, Giammaria, Sarti, Donatella, Patriti, Alberto, Eugeni, Emilio, Guerra, Francesco, Masedu, Francesco, Mackay, Andrew Reay, Guadagni, Stefano
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Inc 2020
Témata:
Observational Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7450817/
https://ncbi.nlm.nih.gov/pubmed/32874953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v11.i6.397
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky